TRPM8 antagonist 2

CAS No. 259674-19-6

TRPM8 antagonist 2 ( —— )

Catalog No. M20423 CAS No. 259674-19-6

TRPM8 antagonist 2 is a potent and selective TRPM8 antagonist with an IC50 of 0.2 nM used in the research of neuropathic pain syndromes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 69 In Stock
10MG 113 In Stock
25MG 195 In Stock
50MG 309 In Stock
100MG 514 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TRPM8 antagonist 2
  • Note
    Research use only not for human use.
  • Brief Description
    TRPM8 antagonist 2 is a potent and selective TRPM8 antagonist with an IC50 of 0.2 nM used in the research of neuropathic pain syndromes.
  • Description
    TRPM8 antagonist 2 is a potent and selective TRPM8 antagonist with an IC50 of 0.2 nM used in the research of neuropathic pain syndromes.
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    TRPM8
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    259674-19-6
  • Formula Weight
    398.5
  • Molecular Formula
    C26H26N2O2?
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:160 mg/mL (401.51 mM)
  • SMILES
    COC(=O)[C@H](Cc1c[nH]c2ccccc12)N(Cc1ccccc1)Cc1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Alessia B Nunzio I Carmine O et al. Identification of a Potent Tryptophan-based TRPM8 Antagonist With in vivo Analgesic Activity[J]. Journal of Medicinal Chemistry 2018:acs.jmedchem.8b00545-.
molnova catalog
related products
  • TRPV4 agonist-1 free...

    TRPV4 agonist-1 free base?is an agonist of transient receptor potential vanilloid 4 (TRPV4;EC50 of 60 nM, in the hTRPV4 Ca2+ assay).

  • AMG-9810

    A potent, selective and competitive TRPV1 antagonist with IC50 of 24.5 and 85.6 nM for human and rat TRPV1, repectively.

  • Berbamine

    Berbamine and its derivatives are promising agents to suppress liver cancer growth by targeting CAMKII.